Researcher Bios

Learn more about the backgrounds, scientific pursuits and personal interests of the members of our research team. These individuals are committed to pursuing Bristol-Myers Squibb’s goal of discovering, developing and delivering transformational medicines to patients.
Beatrice Anduze-Faris, M.D.
Beatrice Anduze-Faris, M.D.

Head of Global Clinical Compliance & Continuous Improvement, Global Clinical Operations

Bryan (Bo) Barnhart, Ph.D.
Bryan (Bo) Barnhart, Ph.D.

Senior Director, Immuno-Oncology, Discovery

Percy Carter
Percy Carter, MBA, Ph.D.

Head of Discovery Chemistry and Molecular Technologies, Drug Discovery Research

Edgar Charles, M.D.
Edgar Charles, M.D.

Clinical Development Lead, pegylated FGF21

Binodh DeSilva
Binodh DeSilva, Ph.D.

Head of Analytical and Bioanalytical Operations, Pharmaceutical Development

Evan Janovitz
Evan Janovitz, DVM, Ph.D., DACVP

Director of Pathology, Discovery Toxicology

Charlotte Jones-Burton
Charlotte Jones-Burton, M.D., M.S.

Global Clinical Program Lead, Cardiovascular Marketed Products

Alan Korman
Alan Korman, Ph.D.

Vice President, Immuno-Oncology Discovery

Michael C. Montalto, Ph.D.
Michael C. Montalto, Ph.D.

Executive Director, Pathology & Clinical Biomarker Laboratories, Translational Medicine

Ryan Moslin, Ph.D.
Ryan Moslin, Ph.D.

Senior Research Investigator, Early Immunology Discovery

Mike Quigley, Ph.D.
Mike Quigley, Ph.D.

Executive Director and Co-Lead, Immuno-Oncology Resistance Biology

Mark Selby
Mark Selby, Ph.D.

Senior Director, Immuno-oncology Discovery

Joseph Szustakowski, Ph.D.
Joseph Szustakowski, Ph.D.

Executive Director, Translational Bioinformatics

John Throup, BSc, Ph.D.
John Throup, BSc, Ph.D.

Development Lead, Immunoscience R&D